Trial: 202007148

ENHANCE: A Randomized, Double-blind, Multicenter Study Comparing Magrolimab in Combination with Azacitidine versus Azacitidine Plus Placebo in Treatment-naïve Patients with Higher Risk Myelodysplastic Syndrome

Phase

III (Cancer Control)

Principal Investigator

Abboud, Camille

Disease Site

Other Hematopoietic

Learn more about this study at: clinicaltrials.gov